Elliott B. Grossbard

2009

In 2009, Elliott B. Grossbard earned a total compensation of $1.3M as Executive Vice President, Chief Medical Officer at Rigel Pharmaceuticals, a 55% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$315,000
Option Awards$539,097
Salary$450,000
Other$3,564
Total$1,307,661

Grossbard received $539.1K in option awards, accounting for 41% of the total pay in 2009.

Grossbard also received $315K in non-equity incentive plan, $450K in salary and $3.6K in other compensation.

Rankings

In 2009, Elliott B. Grossbard's compensation ranked 3,598th out of 9,885 executives tracked by ExecPay. In other words, Grossbard earned more than 63.6% of executives.

ClassificationRankingPercentile
All
3,598
out of 9,885
64th
Division
Manufacturing
1,263
out of 3,690
66th
Major group
Chemicals And Allied Products
246
out of 866
72nd
Industry group
Drugs
144
out of 638
77th
Industry
Pharmaceutical Preparations
114
out of 446
74th
Source: SEC filing on April 12, 2012.

Grossbard's colleagues

We found four more compensation records of executives who worked with Elliott B. Grossbard at Rigel Pharmaceuticals in 2009.

2009

James Gower

Rigel Pharmaceuticals

Chief Executive Officer

2009

Donald Payan

Rigel Pharmaceuticals

Executive Vice President, President of Discovery and Research

2009

Raul Rodriguez

Rigel Pharmaceuticals

Chief Operating Officer

2009

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

You may also like